PNC Financial Services Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

PNC Financial Services Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-200	Closed	-$9K	–	4730
2015 Q3	$9K	Sell	200 -48	-19%	-$2.03K	﹤0.01%	3750
2015 Q2	$10K	Sell	248 -192	-44%	-$8.1K	﹤0.01%	3828
2015 Q1	$17K	Buy	440 +435	+8,700%	+$16.8K	﹤0.01%	3581
2014 Q4	$0	Buy	+5	New	+$177	﹤0.01%	4348
2014 Q3	–	Sell	-116	Closed	-$4K	–	4107
2014 Q2	$4K	Sell	116 -11	-9%	-$376	﹤0.01%	3403
2014 Q1	$5K	Buy	+127	New	+$4.66K	﹤0.01%	3269

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

PNC Financial Services Group's WX Position: Q4 2015 in Review

PNC Financial Services Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 200 shares — an estimated $9K sold.

PNC Financial Services Group first reported a position in WX in Q1 2014 and held it in 6 quarters. The position peaked at $17K in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

PNC Financial Services Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
PNC Financial Services Group sold 200 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $9K.
PNC Financial Services Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 6 quarters.
PNC Financial Services Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $17K in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on PNC Financial Services Group's 13F filing for Q4 2015, filed 5 Feb 2016.